181 related articles for article (PubMed ID: 38151661)
21. A retrospective analysis on the management of pigmented lesions using a picosecond 755-nm alexandrite laser in Asians.
Chan JC; Shek SY; Kono T; Yeung CK; Chan HH
Lasers Surg Med; 2016 Jan; 48(1):23-9. PubMed ID: 26696500
[TBL] [Abstract][Full Text] [Related]
22. Randomised, controlled, double-blind study of combination therapy of oral tranexamic acid and topical hydroquinone in the treatment of melasma.
Shihab N; Prihartono J; Tovar-Garza A; Agustin T; Legiawati L; Pandya AG
Australas J Dermatol; 2020 Aug; 61(3):237-242. PubMed ID: 32109318
[TBL] [Abstract][Full Text] [Related]
23. Laser-assisted delivery of tranexamic acid for melasma: Pilot study using a novel 1927 nm fractional thulium fiber laser.
Wang JV; Christman MP; Feng H; Ferzli G; Jeon H; Geronemus RG
J Cosmet Dermatol; 2021 Jan; 20(1):105-109. PubMed ID: 33174686
[TBL] [Abstract][Full Text] [Related]
24. Melasma: A critical analysis of clinical trials investigating treatment modalities published in the past 10 years.
Spierings NMK
J Cosmet Dermatol; 2020 Jun; 19(6):1284-1289. PubMed ID: 31603285
[TBL] [Abstract][Full Text] [Related]
25. Comparison of therapeutic effects of liposomal Tranexamic Acid and conventional Hydroquinone on melasma.
Banihashemi M; Zabolinejad N; Jaafari MR; Salehi M; Jabari A
J Cosmet Dermatol; 2015 Sep; 14(3):174-7. PubMed ID: 26177992
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of tranexamic acid 5% cream vs hydroquinone 4% cream in treating melasma: A split-face comparative clinical, histopathological, and antera 3D camera study.
El-Husseiny R; Rakha N; Sallam M
Dermatol Ther; 2020 Nov; 33(6):e14240. PubMed ID: 32856757
[TBL] [Abstract][Full Text] [Related]
27. Effectiveness of laser and topical tranexamic acid combination therapy in melasma: An updated systematic review and meta-analysis of randomized controlled trials.
Khan QA; Abdi P; Farkouh C; Anthony MR; Chundru A; Amatul F; Parimi K; Santiago N; Farkouh M; Iram S; Khan A
Lasers Med Sci; 2023 Jun; 38(1):139. PubMed ID: 37326860
[TBL] [Abstract][Full Text] [Related]
28. Treatment of melasma with mixed parameters of 1,064-nm Q-switched Nd:YAG laser toning and an enhanced effect of ultrasonic application of vitamin C: a split-face study.
Lee MC; Chang CS; Huang YL; Chang SL; Chang CH; Lin YF; Hu S
Lasers Med Sci; 2015 Jan; 30(1):159-63. PubMed ID: 25073866
[TBL] [Abstract][Full Text] [Related]
29. Oral tranexamic acid, hydroquinone 4% and low-fluence 1064 nm Q-switched Nd:YAG laser for mixed melasma: Clinical and dermoscopic evaluation.
Elkamshoushi AM; Romisy D; Omar SS
J Cosmet Dermatol; 2022 Feb; 21(2):657-668. PubMed ID: 33826785
[TBL] [Abstract][Full Text] [Related]
30. Photoaging Reversibility in Asian Patients With Melasma Treated Using Picosecond Lasers With a Diffractive Lens Array: A 1-Year Prospective Observational Cohort Study.
Lin ET; Chiang HM; Lin BS; Huang YH; Chang CC
Dermatol Surg; 2021 Jan; 47(1):e10-e14. PubMed ID: 32271179
[TBL] [Abstract][Full Text] [Related]
31. Comparison of 755-nm picosecond alexandrite laser versus 1064-nm Q-switched Nd:YAG laser for melasma: A randomized, split-face controlled, 2-year follow-up study.
Zhou Y; Li Y; Hamblin MR; Wen X
Lasers Surg Med; 2024 Mar; 56(3):263-269. PubMed ID: 38282099
[TBL] [Abstract][Full Text] [Related]
32. Comparison of efficacy and safety of tranexamic acid mesotherapy versus oral tranexamic acid in patients with melasma undergoing Q-switched fractional 1064-nm Nd:YAG laser: A blinded RCT and follow-up.
Behrangi E; Shemshadi M; Ghassemi M; Goodarzi A; Dilmaghani S
J Cosmet Dermatol; 2022 Jan; 21(1):279-289. PubMed ID: 34724323
[TBL] [Abstract][Full Text] [Related]
33. A split face study to document the safety and efficacy of clearance of melasma with a 5 ns q switched Nd YAG laser versus a 50 ns q switched Nd YAG laser.
Alsaad SM; Ross EV; Mishra V; Miller L
Lasers Surg Med; 2014 Dec; 46(10):736-40. PubMed ID: 25411141
[TBL] [Abstract][Full Text] [Related]
34. Melasma treatment with a 1064 nm, picosecond-domain laser with a fractionated multibeam lens array.
Bernstein EF; Basilavecchio LD; Wang J
Lasers Surg Med; 2023 Nov; 55(9):801-808. PubMed ID: 37668307
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of 577 nm pro-yellow laser in the treatment of melasma: a prospective split-face study.
Mohamed EM; Younes AH; Hussein GM
J Cosmet Laser Ther; 2020 Feb; 22(2):107-110. PubMed ID: 32216566
[TBL] [Abstract][Full Text] [Related]
36. Assessment of combined fractional CO
Tawfic SO; Abdel Halim DM; Albarbary A; Abdelhady M
Lasers Surg Med; 2019 Jan; 51(1):27-33. PubMed ID: 30431171
[TBL] [Abstract][Full Text] [Related]
37. Microneedling-assisted topical tranexamic acid solution versus 4% hydroquinone for treating melasma: A split-face randomized study.
Zaky MS; Obaid ZM; Khalil EA; Elsaie ML
J Cosmet Dermatol; 2021 Dec; 20(12):4011-4016. PubMed ID: 34525492
[TBL] [Abstract][Full Text] [Related]
38. Randomized, Double-Blinded, Split-Face Study Comparing the Efficacy and Tolerability of Two Topical Products for Melasma.
Kaufman BP; Alexis AF
J Drugs Dermatol; 2020 Sep; 19(9):822-827. PubMed ID: 33026755
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of microneedling plus topical 4% tranexamic acid solution vs 4% hydroquinone in the treatment of melasma: A single-blind randomized clinical trial.
Shamsi Meymandi S; Mozayyeni A; Shamsi Meymandi M; Aflatoonian M
J Cosmet Dermatol; 2020 Nov; 19(11):2906-2911. PubMed ID: 32406162
[TBL] [Abstract][Full Text] [Related]
40. The first clinical experience on efficacy of topical flutamide on melasma compared with topical hydroquinone: a randomized clinical trial.
Adalatkhah H; Sadeghi-Bazargani H
Drug Des Devel Ther; 2015; 9():4219-25. PubMed ID: 26345129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]